1.
Mykhaloiko IS, Yatsyshyn RI, Dudar IO, Hotsaniuk OI, Kuryliv HM. Safety and efficacy of apixaban in patients with glomerulonephritis and nephrotic syndrome: a prospective longitudinal cohort study. Modern Medical Technology [Internet]. 2025Mar.25 [cited 2025Apr.2];17(1):41-5. Available from: https://medtech.mphu.edu.ua/article/view/320766